BrainAurora Medical Technology Limited released its monthly return for the period ended 31 October 2026, showing no changes in share capital structure and affirming compliance with Hong Kong’s public-float requirements.

Authorised Capital • Authorised share capital remained at 500.00 billion ordinary shares with a par value of USD 0.0000001 each, equivalent to total authorised capital of USD 50,000. • No increase or decrease in authorised or registered shares was recorded during the month.

Issued Shares • Issued share count held steady at 1.36 billion ordinary shares, with zero treasury shares outstanding. • There were no share issuances, cancellations, repurchases, or conversions in October.

Capital Management Instruments • The company reported no outstanding share options, warrants, convertible securities, or other agreements that could lead to additional share issuance.

Public Float • BrainAurora confirmed that it met the Main Board’s minimum public-float requirement of 25% of issued shares as at 31 October 2026.

Governance • The filing was authorised and submitted on 3 November 2026 by Director Tan Zheng.

Overall, BrainAurora’s October update signals a period of capital stability, with the share base and authorised capital unchanged and regulatory float levels fully satisfied.